Novo Nordisk's pioneering diabetes pill impresses in first big study Ruby Khatun Khatun24 Feb 2018 9:45 AM ISTCOPENHAGEN/LONDON: The world’s largest diabetes drugmaker, Novo Nordisk, on Thursday presented the first successful data from a large final-stage...
US health officials reverse stance on flu vaccine of AstraZeneca Ruby Khatun Khatun24 Feb 2018 9:30 AM ISTAstraZeneca Plc said an advisory committee of the U.S. Centers for Disease Control and Prevention recommended the use of its FluMist Quadrivalent...
Glenmark ties up with SCD Pharma for ophthalmic products Ruby Khatun Khatun23 Feb 2018 10:15 AM ISTNew Delhi: Glenmark Pharmaceuticals has entered into an exclusive agreement with South Korea's Sam Chun Dang Pharm. Co. Ltd. (SCD) to develop,...
UP govt committed to pharma, biotech sector growth: Minister Medical Dialogues Bureau23 Feb 2018 9:45 AM ISTLucknow: Union minister of state for health and family welfare Anupriya Patel said the present state government is serious about the development of...
Novo Nordisk gets nod from US drug purchaser for new diabetes hope Ruby Khatun Khatun23 Feb 2018 9:30 AM ISTCOPENHAGEN: Insulin maker Novo Nordisk said its Ozempic diabetes drug had been included on a list of medicines approved for patients covered by U.S....
Lupin gets USFDA final approval to market generic Tamiflu Medical Dialogues Bureau22 Feb 2018 11:00 AM ISTNew Delhi: Drug firm Lupin said it has received final approval from the US health regulator to market its Oseltamivir Phosphate for oral suspension...
Sun Pharma recalls over 17500 bottles of nasal spray from US Ruby Khatun Khatun22 Feb 2018 10:42 AM ISTNew Delhi: Sun Pharmaceutical Industries Inc, the US arm of domestic drug major Sun Pharma, is recalling over 17.5 thousand bottles of from the...
About 50,000 to get employment in Health and Pharma sector in UP Medical Dialogues Bureau22 Feb 2018 10:00 AM ISTLucknow: Uttar Pradesh government has got 27 proposals of Rs 6,362 crore in healthcare and pharmaceutical sectors which will generate about 50,000...
Aimmune's peanut allergy drug meets main goal, shares surge Ruby Khatun Khatun22 Feb 2018 9:45 AM ISTU.S. drug developer Aimmune Therapeutics Inc said on Tuesday its peanut allergy drug met the main goal of an eagerly awaited late-stage study, sending...
Biocon gets 6 observations from USFDA for Malaysia facility Ruby Khatun Khatun21 Feb 2018 2:48 PM ISTNew Delhi: Biotechnology major Biocon Ltd said the US health regulator has made six observations after inspecting its Malaysia manufacturing...
Margins on drugs as high as 1,192 percent in 4 private hospitals: Indian drug price regulator Ruby Khatun Khatun21 Feb 2018 12:30 PM ISTNew Delhi: Non-scheduled drugs and diagnostic services constituted major components of charges billed to patients in four private hospitals with...
344 Fixed-Dose Combinations: DCGI constitutes a sub-committee to relook the matter Ruby Khatun Khatun21 Feb 2018 10:58 AM ISTNew Delhi: Through a recent notification, Directorate General of Health Services has constituted a subcommittee for having a relook in the case of...
